BERKELEY LIGHTS PRESS RELEASES See all the latest Berkeley Lights announcements, including new products, services and partnerships. CATALENT BIOLOGICS ADOPTS BERKELEY LIGHTS’ BEACON® OPTOFLUIDIC PLATFORM TO ACCELERATE CELL LINE DEVELOPMENT - July 10, 2018 — READ > BERKELEY LIGHTS AND CHEMPARTNER COLLABORATE ON ACCELERATING ANTIBODY DISCOVERY Emeryville, Calif. - June 27, 2018 — READ > BERKELEY LIGHTS AND TPG BIOLOGICS ENTER INTO A STRATEGIC COLLABORATION FOR CELL LINE DEVELOPMENT Emeryville, Calif. - May 23, 2018 — READ > BERKELEY LIGHTS’ ANNOUNCES NEW AGREEMENT WITH SANOFI FOR BEACON® OPTOFLUIDIC PLATFORM Emeryville, Calif. - April 19, 2018 — READ > MD ANDERSON AND BERKELEY LIGHTS LAUNCH OPTERA THERAPEUTICS TO ACCELERATE DEVELOPMENT OF CELL THERAPIES FOR CANCER Houston, TX and Emeryville, CA - March 07, 2018 — READ > SHIRE ADOPTS BERKELEY LIGHTS’ BEACON® OPTOFLUIDIC PLATFORM TO SPEED CELL LINE DEVELOPMENT Emeryville, Calif. - January 30, 2018 — READ > ANOTHER LARGE PHARMA IMPLEMENTS BERKELEY LIGHTS’ BEACON® OPTOFLUIDIC PLATFORM FOR ACCELERATING ANTIBODY DISCOVERY Emeryville, Calif. - January 16, 2018 — READ > BERKELEY LIGHTS ANNOUNCES RESEARCH COLLABORATION AND LICENSE AGREEMENT WITH PFIZER Emeryville, Calif. - January 04, 2018 — READ > BERKELEY LIGHTS FORMS STRATEGIC SCIENTIFIC ADVISORY BOARD FEATURING DISTINGUISHED EXPERTS Emeryville, Calif. - December 04, 2017 — READ > TEVA PHARMACEUTICALS AUSTRALIA, PTY. LTD. IMPLEMENTS BERKELEY LIGHTS’ BEACON™ OPTOFLUIDIC PLATFORM FOR ANTIBODY DISCOVERY Emeryville, Calif. - November 29, 2017 — READ > Pagination First page « First Previous page ‹ Previous Page 1 Current page 2 Page 3 Page 4 Next page Next › Last page Last »
